University of Oxford at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

University of Oxford takes part in 6 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions span cancer vaccines, outbreak preparedness and what predicts protection by a vaccine. Topics include the ChAdOx2-LungVax vaccine for preventing lung cancer and natural-experiment evidence linking the recombinant shingles vaccine to lower risk of dementia and cardiovascular events.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Talk
Mon Oct 19
10:00
Workshop Leader’s Opening Remarks
Workshop: Platform Technologies
Talk
Mon Oct 19
11:45
Talk
Tue Oct 20
16:30
Talk
Wed Oct 21
10:30
From crisis to preparedness: vaccine development during and between outbreaks lessons from the Bundibugyo virus (BDBV) PHEIC
Emerging & Infectious Diseases
Panel
Wed Oct 21
10:45
Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response
How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain.
with UK Health Security Agency (UKHSA), CSL Seqirus, GSK +1 more
Talk
Wed Oct 21
14:15
Neutralising antibody is a poor predictor of protection by candidate EBV vaccines
Emerging & Infectious Diseases

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of Oxford

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction